Listen time: 27m 23s

About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Visit our Heart Failure Management Hub to discover a range of educational content to facilitate the use of SGLT-2 inhibitors and other guideline directed medical therapies as foundational treatment for HF.

Articles

A14 - Haemodynamic and Metabolic Changes Due to Left Ventricular Unloading by Impella Heart Pump in Patients Suffering from Cardiogenic Shock Within 24 Hours: Results from the Jenamacs Impella Registry

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A14.

A12 - Upward Shift of Cardiac Output Curve Determined by the Synergistic Effect of Support Flow and Left Ventricular Ejection Fraction is the Fundamental Mechanism to Improve Haemodynamics by Left Ventricular Assist Device

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A12.

A7 - Concept and Design of the Novel, Percutaneous, Pulsatile Left Ventricular Assist Device PERKAT-LV

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A7.

A4 - Use of a Percutaneous Temporary Mechanical Circulatory Support as a Bridge to Decision in Advanced Heart Failure Patients Listed for Heart Transplantation

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A4.